Bi-Specific 3rd Generation CAR T therapy is a revolutionary advancement in cellular immunotherapy, primarily used to treat blood cancers such as leukemia, lymphoma, and multiple myeloma.

The uptick in Concord Biotech share price came after the company was granted final approval from the USFDA for marketing its ...

Medicamen Biotech stock rose following the announcement of a strategic partnership with XGX Pharma, a European company.

The company is expanding its focus ... in large batches for the wider population. Bharat Biotech said it intends to focus more on the latter. India, compared to global peers, is still in the ...

Bharat Biotech International Limited on Thursday announced the launch of India’s only vertically ... genetic diseases like hemophilia,” the company said in a statement. The company claims ...

Vodafone Idea, NTPC, Concord Biotech, HAL, IRB Infrastructure, NTPC Green Energy and BPCL will be in the spotlight on ...

Indian drugmaker Sun Pharmaceutical Industries (BSE: 524715) revealed it has launched fexuprazan tablets 40mg in India under ...

Vaccine maker Bharat Biotech International Ltd (BBIL) has set up India’s only vertically integrated ... adding that Bharat Biotech is the only company in the developing world which conducted ...

TechInvention and Quantoom Biosciences partner to establish an mRNA platform in India, aiming to boost local production of ...

For decades, Bharat Biotech has led India’s effort in developing and ... who is spearheading the CGT foray, said the company has already deployed 60% of the investment in the facility and ...

HYDERABAD (Reuters) -Indian vaccine maker Bharat Biotech said on Thursday it had invested $75 million in its first cell and gene therapy (CGT) facility in the southern Indian state of Telangana and ...